ES2132046T3 - Sintasas isoprenoides quimericas y usos de las mismas. - Google Patents

Sintasas isoprenoides quimericas y usos de las mismas.

Info

Publication number
ES2132046T3
ES2132046T3 ES97921142T ES97921142T ES2132046T3 ES 2132046 T3 ES2132046 T3 ES 2132046T3 ES 97921142 T ES97921142 T ES 97921142T ES 97921142 T ES97921142 T ES 97921142T ES 2132046 T3 ES2132046 T3 ES 2132046T3
Authority
ES
Spain
Prior art keywords
isoprenoid
polypeptide
domain
chemeric
synthease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97921142T
Other languages
English (en)
Other versions
ES2132046T1 (es
Inventor
Joseph Chappell
Kyoungwhan Back
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Kentucky
Original Assignee
University of Kentucky
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Kentucky filed Critical University of Kentucky
Publication of ES2132046T1 publication Critical patent/ES2132046T1/es
Application granted granted Critical
Publication of ES2132046T3 publication Critical patent/ES2132046T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Nutrition Science (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

EN LA PRESENTE INVENCION SE DESCRIBE UN POLIPEPTIDO DE SINTETASA ISOPRENOIDE QUIMERICA QUE INCLUYE UN PRIMER DOMINIO PROCEDENTE DE UNA PRIMERA SINTETASA ISOPRENOIDE QUE SE UNE A UN SEGUNDO DOMINIO PROCEDENTE DE UNA SINTETASA ISOPRENOIDE HETEROLOGA, EN DONDE, LA SINTETASA ISOPRENOIDE QUIMERICA ES CAPAZ DE CATALIZAR LA OBTENCION DE PRODUCTOS DE REACCION ISOPRENOIDES QUE NO SE PRODUCEN EN AUSENCIA DEL SEGUNDO DOMINIO DE DICHA SINTETASA ISOPRENOIDE HETEROLOGA. TAMBIEN SE DESCRIBE UN POLIPEPTIDO DE SINTETASA ISOPRENOIDE QUIMERICA QUE INCLUYE UN DOMINIO HOMOLOGO COLOCADO ASIMETRICAMENTE, EN DONDE, DICHA SINTETASA ES CAPAZ DE CATALIZAR LA OBTENCION DE PRODUCTOS DE REACCION ISOPRENOIDES, QUE NO SE PRODUCEN CUANDO DICHO DOMINIO SE COLOCA EN LA POSICION EN QUE SE ENCUENTRA EN LA NATURALEZA EN DICHO POLIPEPTIDO DE SINTETASA ISOPRENOIDE.
ES97921142T 1996-04-12 1997-04-11 Sintasas isoprenoides quimericas y usos de las mismas. Expired - Lifetime ES2132046T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/631,341 US5824774A (en) 1996-04-12 1996-04-12 Chimeric isoprenoid synthases and uses thereof

Publications (2)

Publication Number Publication Date
ES2132046T1 ES2132046T1 (es) 1999-08-16
ES2132046T3 true ES2132046T3 (es) 2003-03-16

Family

ID=24530791

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97921142T Expired - Lifetime ES2132046T3 (es) 1996-04-12 1997-04-11 Sintasas isoprenoides quimericas y usos de las mismas.

Country Status (26)

Country Link
US (2) US5824774A (es)
EP (2) EP0904095B1 (es)
JP (4) JP2000508899A (es)
KR (1) KR20000005385A (es)
AP (1) AP808A (es)
AR (1) AR006638A1 (es)
AT (1) ATE223225T1 (es)
AU (1) AU2726497A (es)
BR (1) BR9708650A (es)
CA (1) CA2250712C (es)
CZ (1) CZ294613B6 (es)
DE (2) DE904095T1 (es)
EA (1) EA001622B1 (es)
ES (1) ES2132046T3 (es)
GR (1) GR990300025T1 (es)
HK (1) HK1017275A1 (es)
ID (1) ID19769A (es)
IL (2) IL126486A0 (es)
IN (1) IN186316B (es)
OA (1) OA10895A (es)
PL (1) PL329404A1 (es)
PT (1) PT904095E (es)
TR (1) TR199802043T2 (es)
TW (1) TW509724B (es)
WO (1) WO1997038703A1 (es)
ZA (1) ZA973108B (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5824774A (en) * 1996-04-12 1998-10-20 Board Of Trustees Of The University Of Kentucky Chimeric isoprenoid synthases and uses thereof
US8106260B2 (en) * 1996-04-12 2012-01-31 The Board Of Trustees Of The University Of Kentucky Chimeric isoprenoid synthases and uses thereof
US7186891B1 (en) * 1996-04-12 2007-03-06 University Of Kentucky, Research Foundation Plant cells and plants expressing chimeric isoprenoid synthases
US5945726A (en) * 1996-12-16 1999-08-31 Micron Technology, Inc. Lateral bipolar transistor
AR022383A1 (es) 1998-09-18 2002-09-04 Univ Kentucky Res Found Sintasas
US6358712B1 (en) 1999-01-05 2002-03-19 Trustee Of Boston University Ordered gene assembly
EP1141275B1 (en) * 1999-01-05 2009-08-12 Trustees Of Boston University Improved nucleic acid cloning
US20040005673A1 (en) * 2001-06-29 2004-01-08 Kevin Jarrell System for manipulating nucleic acids
US20030033626A1 (en) 2000-07-31 2003-02-13 Hahn Frederick M. Manipulation of genes of the mevalonate and isoprenoid pathways to create novel traits in transgenic organisms
AU2013204829B2 (en) * 2001-03-09 2013-07-04 University Of Kentucky Research Foundation Cytochrome P450s and uses thereof
US7405057B2 (en) * 2001-03-09 2008-07-29 Board Of Trustees Of The University Of Kentucky Cytochrome P450s and uses thereof
AU2012202780B2 (en) * 2001-03-09 2014-07-03 University Of Kentucky Research Foundation Cytochrome P450s and Uses Thereof
US7192751B2 (en) * 2001-12-06 2007-03-20 The Regents Of The University Of California Biosynthesis of amorpha-4,11-diene
US7172886B2 (en) * 2001-12-06 2007-02-06 The Regents Of The University Of California Biosynthesis of isopentenyl pyrophosphate
US7442785B2 (en) * 2003-07-24 2008-10-28 The University Of Kentucky Research Foundation Sesquiterpene synthase gene and protein
US8124811B2 (en) 2007-03-20 2012-02-28 Allylix, Inc. Fragrance and methods for production of 5-epi-β-vetivone, 2-isopropyl-6,10-dimethyl-spiro[4.5]deca-2,6-dien-8-one, and 2-isopropyl-6,10-dimethyl-spiro[4.5]deca-1,6-dien-8-one
MX2009012839A (es) 2007-06-01 2010-02-24 Sapphire Energy Seleccion quimica ultrarrapida de organismos fotosinteticos modificados geneticamente.
GB2463543A (en) * 2007-09-11 2010-03-24 Sapphire Energy Inc Molecule production by photosynthetic organisms
EP2203542A1 (en) 2007-09-11 2010-07-07 Sapphire Energy, Inc. Methods of producing organic products with photosynthetic organisms and products and compositions thereof
DK2235190T3 (en) * 2007-12-13 2018-07-23 Danisco Us Inc COMPOSITIONS AND PROCEDURES FOR PRODUCING ISOPRENE
US8034992B2 (en) * 2008-06-16 2011-10-11 Academia Sinica Gibberellin 2-oxidase genes and uses thereof
US8481286B2 (en) * 2008-08-12 2013-07-09 Allylix, Inc. Method for production of isoprenoid compounds
BR112013010244A2 (pt) 2010-10-29 2016-07-05 Allylix Inc polipeptídeos de valenceno sintase modificados que codificam moléculas de ácido nucleico e seus usos
US9550815B2 (en) 2012-01-23 2017-01-24 University Of British Columbia ABC terpenoid transporters and methods of using the same
JP5950253B2 (ja) * 2012-02-13 2016-07-13 住友ゴム工業株式会社 イソプレノイドの製造方法、及びイソプレノイド
EP2880159A1 (en) 2012-07-30 2015-06-10 Allylix, Inc. Sclareol and labdenediol diphosphate synthase polypeptides encoding nucleic acid molecules and uses thereof
JP2015533285A (ja) 2012-11-01 2015-11-24 ザ・ユニバーシティ・オブ・ブリティッシュ・コロンビア シトクロムｐ４５０およびシトクロムｐ４５０レダクターゼポリペプチド、コードする核酸分子、ならびにそれらの用途
PL2970934T3 (pl) 2013-03-14 2018-01-31 Evolva Inc Polipeptydy syntazy walencenu, kodujące cząsteczki kwasu nukleinowego oraz ich zastosowania
CN111621508B (zh) * 2020-06-11 2022-07-01 云南中烟工业有限责任公司 烟草萜类合成酶NtTPS7基因及其载体与应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69420957T2 (de) * 1993-04-02 2000-01-13 Pioneer Hi Bred Int Bekämpfung von diabrotica undecimpunctata mittels limonen
CA2118071C (en) * 1993-10-28 2004-09-14 Rodney B. Croteau Dna encoding limonene synthase from mentha spicata
US5824774A (en) * 1996-04-12 1998-10-20 Board Of Trustees Of The University Of Kentucky Chimeric isoprenoid synthases and uses thereof

Also Published As

Publication number Publication date
ATE223225T1 (de) 2002-09-15
BR9708650A (pt) 1999-08-03
IL126486A (en) 2006-04-10
TR199802043T2 (xx) 1999-01-18
US6072045A (en) 2000-06-06
GR990300025T1 (en) 1999-07-30
AU2726497A (en) 1997-11-07
DE904095T1 (de) 1999-10-07
US5824774A (en) 1998-10-20
IN186316B (es) 2001-08-04
ES2132046T1 (es) 1999-08-16
JP2000508899A (ja) 2000-07-18
AP808A (en) 2000-02-29
EP0904095B1 (en) 2002-09-04
DE69715192D1 (de) 2002-10-10
CZ294613B6 (cs) 2005-02-16
AR006638A1 (es) 1999-09-08
WO1997038703A1 (en) 1997-10-23
PL329404A1 (en) 1999-03-29
EP1229122A3 (en) 2002-10-09
EP0904095A1 (en) 1999-03-31
KR20000005385A (ko) 2000-01-25
EP0904095A4 (en) 1999-07-07
ZA973108B (en) 1997-11-04
JP2012005499A (ja) 2012-01-12
EP1229122A2 (en) 2002-08-07
AP9700971A0 (en) 1997-07-31
PT904095E (pt) 2002-12-31
OA10895A (en) 2001-10-11
CA2250712A1 (en) 1997-10-23
IL126486A0 (en) 1999-08-17
TW509724B (en) 2002-11-11
EA199800917A1 (ru) 1999-04-29
HK1017275A1 (en) 1999-11-19
EA001622B1 (ru) 2001-06-25
JP2015171387A (ja) 2015-10-01
JP2015057074A (ja) 2015-03-26
CA2250712C (en) 2008-07-08
ID19769A (id) 1998-07-30
CZ317998A3 (cs) 1999-02-17
DE69715192T2 (de) 2003-04-30

Similar Documents

Publication Publication Date Title
ES2132046T3 (es) Sintasas isoprenoides quimericas y usos de las mismas.
EA200100819A1 (ru) Способ получения мембранных пузырьков
ES2142569T3 (es) Procedimientos y compuestos para la deteccion magneto-relaxometrica de analitos y su utilizacion.
CY1106790T1 (el) Μονοκλωνικα αντισωματα ειδικα δια τον εξωκυτταρικο τομεα του αντιγονου μεμβρανης που ειναι ειδικο για τον προστατη
PT990047E (pt) Metodos e composicoes para a analise de acidos nucleicos por espectroscopia de massa.
ES2191702T3 (es) Fv monocatenarios anti-egfr y anticuerpos anti-egfr.
PT1066060E (pt) Celulas estaminais mesenquimais como imunossupressores
ES2145580T3 (es) Metodos y composiciones para analizar moleculas de acido nucleico que emplean tecnicas basadas en el tamaño.
ES2156154T3 (es) Elementos de un par de union especifica con un grupo quimico unido covalentemente en el sitio de union; produccion y seleccion de los mismos.
BR0314814A (pt) Variantes otimizadas de fc e métodos para sua geração
DE69623005D1 (de) Verbesserte verfahren zur enzymatischen synthese von oligosacchariden
TR199902426T2 (xx) Bitki b�ceklerinin kontrol�.
ES2114514T1 (es) Conjunto de rodillo para fresar carreteras y metodo de fresado.
NO20030495L (no) Peptider som presenteres av celler
ES2169025T3 (es) Compuestos, vectores y procedimiento para expresar fosfolipasa a2 citosolica humana.
ATE414795T1 (de) Antikörperbibliotheken
EA200200974A1 (ru) Моноклональные антитела к рецептору лпнп человека, их получение и применение
DK0906443T3 (da) Generering af replikerende molekyler in vivo
ATE403864T1 (de) Verfahren zur identifizierung von substanzen, die die aktivität von hyperpolarisations-aktivierten kationen-kanälen modulieren
BR9712585A (pt) Processo de colocar em evidência contaminantes microbiológicos vivos em uma amostra de produto para uso alimentìcio
ES2133820T3 (es) Marcador para patologias que implican una reaccion autoinmune y/o para enfermedades inflamatorias.
ES2099678B1 (es) Procedimiento para la inactivacion de virus en proteinas.
ES2179908T3 (es) Acidos sacarosamonocarboxilicos acilados.
UY26170A1 (es) Antigeno (c42) asociados a tumores
DE60136747D1 (de) Mitochondrialen membrane permeabilisierung durch hiv-1 vpr und screeningsverfahren